建發股份(600153.SH):控股股東增持1.03%股份
格隆匯5月15日丨建發股份(600153.SH)公佈,2020年5月8日,公司發佈《關於公司控股股東增持公司股票及後續增持計劃公告》,公司控股股東建發集團於2020年5月7日通過上海證券交易所交易系統集中競價交易方式增持了公司股份,並計劃在首次增持後的3個月內累計增持(含首次增持)股份數量不超過公司總股本的2%。
截至2020年5月14日,建發集團通過上海證券交易所交易系統集中競價交易方式增持公司股份2917.07萬股,佔公司總股本1.03%。本次權益變動後,控股股東持有上市公司股份比例從45.89%增加至46.92%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.